#ChoiceBroking #MorningTea: Wall Street treaded water on Thursday following two days of strong gains as advancing utilities offset declines in materials, banks and other cyclical industries.
Q3 2024 Earnings Conference Call and Webcast Slides
Morning tea 27 05-2016
1. SEBI Certified – Research Analyst www.choiceindia.com
Global View
India Update
Today’s Event/ Stock in News
Oil and Natural Gas Corporation Limited (ONGC) delivered better-than-expected earnings for the fourth quarter ended March 31,
2016, helped by increase in other income and exceptional gain. “Dehradun-headquartered firm has reported a growth of 12.2 per
cent in its standalone net profit at Rs 4,416.11 crore as compared to Rs 3,935.07 crore in the same period last year,” ONGC said in
a filing to BSE on Thursday.
Technical Outlook: On daily chart, stock has given close above its 100 day moving average which is placed at 213.35 level, which
shows that short to medium term trend is up and stock could accelerates its upside movement from the present level. Moreover,
stock has given breakout of 215 level, which acted as strong resistance in past, indicates for robust upside movement that can be
seen in next few trading session. A momentum indicator RSI reading is at 56.42 level with positive crossover, which point out for
positive breath in the stock. So for trading perspective, one could Buy in the range of 214-216 for the Target of 221 with the SL of
211.50
ONGC
TORNTPHARMA
SEBI Registered – Research Analyst www.choiceindia.com * Please Refer Disclaimer on Website
Morning Tea
27th May 2016
Buy in the range of 1377-1383 for the Target of 1410 with the SL of 1363
Buy in the range of 214-216 for the Target of 221 with the SL of 211.50
Ahmedabad-based Torrent Pharma is in advanced talks to buy bulk drugs supplier Glochem Industries for about Rs 300 crore,
people aware of the development said. Glochem is a medium-sized company that makes bulk drugs, or active ingredients, which
are used as raw material for medicines. The privately held company owns a few USFDA-approved sites in Hyderabad and Vizag
where oral bulk actives are manufactured.
Technical Outlook: On daily chart, stock has managed to close above its 100 day moving average which is placed at 1368 level,
which shows that medium trend has become change to positive and stock could accelerates its upside movement from the
present level. Besides, we have observed good volume activity during last two trading days, which point out for gradually building
up positive momentum in the stock. A momentum indicator RSI reading is at 49.28 with positive crossover, which point out for
positive breath in the stock. So for trading perspective, one could Buy in the range of 1377-1383 for the Target of 1410 with the
SL of 1363.
Wall Street treaded water on Thursday following two days of strong gains as advancing utilities offset declines in materials, banks
and other cyclical industries. Investors this week have grown more comfortable with expectations the Federal Reserve could raise
interest rates as soon as June, with many taking the view that such a hike would reflect improvement in the country's economy.
After gaining 2 percent over the previous two sessions, the S&P 500 traded flat, with a 1.1 percent dip in the materials index
partly offset by a 1.06 percent rise in utilities . "People are taking their foot off the gas after making a bunch of money, and now
they're waiting for the next data point," said Phil Blancato, chief executive of Ladenburg Thalmann Asset Management in New
York.
Ignoring the flat US close, the Indian equity benchmark is likely to open strong on back of a stellar close on Thursday. The market
indicator SGX Nifty too is 24 points up at around 8105. Markets in Asia too have begun the final trading day of the week higher.
The Wall Street closed mixed with the Dow failing to build upon its best two-day point gain since early March but Nasdaq eked
out a 3-day winning streak ahead of Yellen's speech today. In Europe also indexes closed tad higher on Thursday, after a choppy
session in which investors tried to make sense of the fluctuating oil price. Back home the bulls have taken complete control over
Dalal Street , value buying in infra (majorly L&T) and banks helped the Sensex and Nifty end at fresh 2016 closing high.
3. SEBI Certified – Research Analyst www.choiceindia.com
Bulk Deal
SEBI Certified – Research Analyst www.choiceindia.com
Morning Tea
27th May 2016
Security in Ban
SEBI Registered – Research Analyst www.choiceindia.com * Please Refer Disclaimer on Website
Sr. No. Deal Date Script Code Security Name Client Name Deal Type Quantity Price
1 26/05/2016 531217 WESTE MOHUR INVESTMENT AND CONSULTANCY PVT B 1500000 2.00
2 26/05/2016 514366 CITIZYN PUNAJI SOMAJI THAKOR S 492730 5.06
3 26/05/2016 514366 CITIZYN PUNAJI SOMAJI THAKOR B 464071 5.06
4 26/05/2016 519588 DFM THE DELHI FLOUR MILLS COMPANY LTD S 450000 1715.00
5 26/05/2016 512257 SVARTCORP UPSURGE INVESTMENT AND FINANCE LTD S 450000 3.11
6 26/05/2016 533506 INVENTURE ASHOK COMMERCIAL ENTERPRISES B 448250 26.43
7 26/05/2016 539658 TEAMLEASE HDFC MUTUAL FUND B 372000 930.01
8 26/05/2016 539658 TEAMLEASE DSP BLACKROCK MUTUAL FUND S 371666 930.00
9 26/05/2016 539331 VETO AKSHAY KUMAR GURNANI S 350000 118.82
10 26/05/2016 519588 DFM STEADVIEW CAPITAL MAURITIUS LIMITED B 274480 1715.00
4. SEBI Certified – Research Analyst www.choiceindia.com
Contact Us
www.choiceindia.com
www.choiceindia.comcustomercare@choiceindia.com
Disclaimer
This is solely for information of clients of Choice Broking and does not construe to be an investment advice. It is also not intended as an offer or solicitation for the purchase and sale of any financial
instruments. Any action taken by you on the basis of the information contained herein is your responsibility alone and Choice Broking its subsidiaries or its employees or associates will not be liable in
any manner for the consequences of such action taken by you. We have exercised due diligence in checking the correctness and authenticity of the information contained in this recommendation, but
Choice Broking or any of its subsidiaries or associates or employees shall not be in any way responsible for any loss or damage that may arise to any person from any inadvertent error in the
information contained in this recommendation or any action taken on basis of this information. Technical analysis studies market psychology, price patterns and volume levels. It is used to forecast
future price and market movements. Technical analysis is complementary to fundamental analysis and news sources. The recommendations issued herewith might be contrary to recommendations
issued by Choice Broking in the company research undertaken as the recommendations stated in this report is derived purely from technical analysis. Choice Broking has based this document on
information obtained from sources it believes to be reliable but which it has not independently verified; Choice Broking makes no guarantee, representation or warranty and accepts no responsibility
or liability as to its accuracy or completeness. The opinions contained within the report are based upon publicly available information at the time of publication and are subject to change without
notice. The information and any disclosures provided herein are in summary form and have been prepared for informational purposes. The recommendations and suggested price levels are intended
purely for trading purposes. The recommendations are valid for the day of the report however trading trends and volumes might vary substantially on an intraday basis and the recommendations may
be subject to change. The information and any disclosures provided herein may be considered confidential. Any use, distribution, modification, copying, forwarding or disclosure by any person is
strictly prohibited. The information and any disclosures provided herein do not constitute a solicitation or offer to purchase or sell any security or other financial product or instrument. The current
performance may be unaudited. Past performance does not guarantee future returns. There can be no assurance that investments will achieve any targeted rates of return, and there is no guarantee
against the loss of your entire investment.
POTENTIAL CONFLICT OF INTEREST DISCLOSURE (as on date of report) Disclosure of interest statement – • Analyst interest of the stock /Instrument(s): - No. • Firm interest of the stock /
Instrument (s): - No.
SEBI Certified – Research Analyst www.choiceindia.com
Research Team
Mr. Sumeet Bagadia Associate Director
Kunal Parmar Research Associate
Amit Pathania Research Associate
Vikas Chaudhari Research Associate
Kapil Shah Research Associate
Rajnath Yadav Research Associate
Satish Kumar Research Associate
Morning Tea
27th May 2016
SEBI Registered – Research Analyst www.choiceindia.com * Please Refer Disclaimer on Website
Kapil Shah
Digitally signed by Kapil Shah
DN: cn=Kapil Shah, o=Choice Equity Broking
Pvt Ttd., ou=Research Department,
email=kapil.shah@choiceindia.com, c=IN
Date: 2016.05.27 08:48:01 +05'30'